Cargando…
Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma
Circulating microRNAs (miRNAs) are emerging as promising biomarkers for cancer; however, the significance of circulating miRNAs in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) remains largely unknown. Based on our prior observations that miRNA-101 (miR-101) is downregulated by HBV...
Autores principales: | FU, YU, WEI, XUFU, TANG, CHENGYONG, LI, JIANPING, LIU, RUI, SHEN, AI, WU, ZHONGJUN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834113/ https://www.ncbi.nlm.nih.gov/pubmed/24260081 http://dx.doi.org/10.3892/ol.2013.1638 |
Ejemplares similares
-
MiR-101 targets DUSP1 to regulate the TGF-β secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma
por: Wei, Xufu, et al.
Publicado: (2015) -
Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis
por: Mou, Tong, et al.
Publicado: (2017) -
IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling
por: Liu, Rui, et al.
Publicado: (2016) -
Expression of the microRNA-143/145 cluster is decreased in hepatitis B virus-associated hepatocellular carcinoma and may serve as a biomarker for tumorigenesis in patients with chronic hepatitis B
por: Zhao, Qi, et al.
Publicado: (2018) -
Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jin, Yu, et al.
Publicado: (2019)